…
ponsored by Eli Lilly
first monoclonal
Regeneron. The
re, however;
e than 20 new
rch studies that aim
derstand and battle
an additional study being investigated
by Thomas Cox, PsyD, director of faculty
development and education research
in graduate medical education at Baylor
University Medical Center, on the risk
of suicide for medical clinicians and
physicians during and after a pandemic.
se important
h initiatives include
rials targeting
ation caused by
s, research focused
a antibodies, and
geting the virus itself.
itionally, the
9 research
is committed
rstanding the
ogical impact this
ic has on society
philanthropically
studies that will help
nd how individuals
mental resilience
by Ann Marie
center director for
SWRI, these initiatives
data on more than
will investigate the
logical symptoms,
nxiety, depression
ress disorder as
9 pandemic. They
y in those subjects
ng despite the
find ways to bring
Communities
rovided a generous
second phase
h, and to support
Funding the Innovation
Extending investigational expertise
across more than 50 medical specialties,
Baylor Scott & White Research Institute
provides the business and regulatory
expertise to accelerate medical
breakthroughs and innovative new
treatment models through clinical and
translational activities. At outpatient
sites and hospitals across the System,
BSWRI conducts nearly 2,000 active
trials each year.
For decades, BSW Dallas Foundation
has received generous support from
donors to help advance clinical trials
and investigator-initiated studies. Without
this donor support and Baylor Scott &
White’s dedication and commitment to
advancing healthcare through research,
these potentially lifesaving trials would
not be possible.
“It’s so important for people to get
involved and help fund studies like these,”
said Dr. Mack. “This is critical research
that is going to not only help beat this virus
but in addition make an impact on the
way we practice healthcare in the future.”
For more information on opportunities
to help fund research that will advance
the care for COVID-19 and beyond, please
contact Sarah Burdi at 214.820.4721 or
[email protected].
White Research Institute is uniquely prepared to help fight this pandemic because of
its infrastructure and experience with similar experimental research efforts.